Literature DB >> 8980921

Paracetamol metabolism in two ethnically different Spanish populations.

A Esteban1, R Calvo, M Pérez-Mateo.   

Abstract

The 24 h urinary excretion of paracetamol and its metabolites following a single oral dose of 1.5 g was compared in two ethnically different Spanish populations: 39 volunteers from the Basque country and 32 from Alicante. The urinary concentrations of unchanged paracetamol and its glucuronide, sulphate, cysteine, and mercapturic acid conjugates were determined by high-performance liquid chromatography. Statistically significant differences in the urinary excretion of unchanged paracetamol and the fractional urinary recovery of each conjugate between subjects from Alicante and subjects from the Basque country were not found. In both populations, an inverse relationship between glucuronide and sulphate conjugation following a bimodal frequency distribution pattern was found. In contrast to paracetamol oxidation, intersubject variation in paracetamol conjugation was negligible. The urinary excretion of unchanged paracetamol was higher in smokers than in nonsmokers. As compared with other studies, the urinary excretion of oxidation-derived paracetamol metabolites in both Spanish populations was intermediate and significantly different than that found in Caucasians from Scotland and West Africans (Ghana). This may determine a susceptibility to paracetamol hepatotoxicity following overdosage in the Spanish population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980921     DOI: 10.1007/BF03189719

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  19 in total

1.  Are the Basques a single and a unique population?

Authors:  A Aguirre; A Vicario; L I Mazón; A Estomba; M Martínez de Pancorbo; V Arrieta Picó; F Perez Elortondo; C M Lostao
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

2.  Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy.

Authors:  J R Mitchell; S S Thorgeirsson; W Z Potter; D J Jollow; H Keiser
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

3.  Inter-subject and ethnic differences in paracetamol metabolism.

Authors:  J A Critchley; G R Nimmo; C A Gregson; N M Woolhouse; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

4.  Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning?

Authors:  J A Critchley; E H Dyson; A W Scott; D R Jarvie; L F Prescott
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

5.  Gilbert's disease: a risk factor for paracetamol overdosage?

Authors:  A Esteban; M Pérez-Mateo
Journal:  J Hepatol       Date:  1993-06       Impact factor: 25.083

Review 6.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

7.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

9.  Sources of interindividual variations in acetaminophen and antipyrine metabolism.

Authors:  R M Nash; L Stein; M B Penno; G T Passananti; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

10.  Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.

Authors:  S M de Morais; J P Uetrecht; P G Wells
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

View more
  4 in total

1.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

2.  Heterogeneity of paracetamol metabolism in Gilbert's syndrome.

Authors:  A Esteban; M Pérez-Mateo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.441

3.  Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

Review 4.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.